[ad_1] The oral anticoagulant without vitamin K antagonist (NOAC), an oral anticoagulant without vitamin K, competes to gain dominance in high risk groups of atrial fibrillation. In fact, none of the NOACs …
Read More »[약업신문] Targeting High Risk Atrial Fibrillation & # 39; … NOAC competing on a large scale
